Our mission
Our mission
Our strategy
Our presentations
Our videos
Our why
Value of medicines
Featured presentations
How to Kill The Conversation That Makes Innovation Possible.
What’s the big deal about cutting the top-selling drugs down to just being reasonably profitable?
How public funding, incentives, and private funding function together to enable all of us to get what we want: new medicines.
Who we are
Our team
Patient Advocate Action Collective
Innovation Council
Life science builders
Supporters
Featured presentations
How to Kill The Conversation That Makes Innovation Possible.
What’s the big deal about cutting the top-selling drugs down to just being reasonably profitable?
How public funding, incentives, and private funding function together to enable all of us to get what we want: new medicines.
Patients
Help for patients
Take action
How-tos
Featured resources
I've received a bill for in-person care that I can't pay
I've received a bill for a medication that I can't pay
I need in-person care but can't pay for it
Policy
Our priorities
Our presentations
Value of medicines
Letters to Washington
Small Molecule R&D Parity
Our Webinars
News & updates
Research projects
Featured presentations
How to Kill The Conversation That Makes Innovation Possible.
What’s the big deal about cutting the top-selling drugs down to just being reasonably profitable?
How public funding, incentives, and private funding function together to enable all of us to get what we want: new medicines.
Out-of-Pocket Report
Become a First Responder & Thought Partner
Explainers
Why Won't Insurance Cover the Medication Your Doctor Prescribed?
Explainers
Michael Schroeder
NPLB Book Club
Explainers
Explainers
Medical Debt, By the Numbers
Explainers
Turning No Into Yes: How to Fight Your Health Insurance Company and Win
Deborah D. Gordon
Explainers
When Pharmacy Middlemen Save on Medicines, Why Don't You Save Money, Too?
Michael Schroeder
Explainers
Is “Experimental” Just Another Way For Your Insurer to Deny Coverage? Medical Experts Wonder, Too.
Deborah D. Gordon
Explainers
Words You Dread Hearing From Your Health Insurer -- And What To Do Then
Michael Schroeder
Explainers
Discussing Prices and Payment is Hard: Doctors and Patients Need to Do It Anyway
Deborah D. Gordon
Explainers
5 Things a Good Prescription Drug Plan Should Include
Tiffany Onyejiaka
Explainers
What's the Difference Between Generic, Brand-Name and Biosimilar Drugs?
Tom Culman
Explainers
Health Insurance Issues: It's Not Always Time to Call a Lawyer, but Sometimes It Is
Julie Fenyes
Explainers
PBMs: The Secretive Middlemen for Insurance and Drug Companies
Tom Culman
Explainers
Buying Medications From Another Country Can Be Cheaper Even With Insurance
Virginia Pelley
Explainers
What Does the American Rescue Plan Act Mean For You?
Jeffrey Billman
Explainers
Millions of Low-Income Americans Could Get Medicaid Under the ARPA – If Politics Don’t Get in the Way
Deborah D. Gordon
Did you know?
Increasing out-of-pocket costs by just $10 per prescription causes a 33% rise in mortality because fewer patients take the drugs their doctors prescribe.
Source: National Bureau of Economic Research, https://www.nber.org/papers/w28439
Get involved
.jpeg)
.png)
%20(1)%20(1)%20(1)%20(1)%20(1)%20(1)%20(1)%20(1).jpg)
%20(1).jpg)
%20(1)%20(1)%20(1).jpg)
